Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission C. E. ShawP. R. DunbarT. J. Neale Original Communication Pages: 53 - 58
Diffuse Lewy body disease as substrate of primary lateral sclerosis Johann A. HainfellnerPeter PilzHerbert Budka Original Communication Pages: 59 - 63
HLA complement gene polymorphisms in multiple sclerosis Diego FranciottaElisabetta DondiMariaclara Cuccia Original Communication Pages: 64 - 68
Focal brain lesions in patients with AIDS: Aetiologies and corresponding radiological patterns in a prospective study Helmuth SteinmetzGabriele ArendtThomas Kahn Original Communication Pages: 69 - 74
Cerebellar ataxia in patients with Leber's hereditary optic neuropathy Itaru FunakawaHiroshi KatoShigeo Miyazaki Original Communication Pages: 75 - 77
The isolation of calculation skills Martin N. RossorElizabeth K. WarringtonLisa Cipolotti Original Communication Pages: 78 - 81
Immunoblot analysis of sarcoplasmic calcium binding proteins in Duchenne muscular dystrophy Irena Niebrój-DoboszMiroslawa ŁukasiukI. Niebrój-Dobosz Original Communication Pages: 82 - 86
Aphasia and infarction of the posterior cerebral artery territory J. ServanP. VerstichelG. Rancurel Original Communication Pages: 87 - 92
The significance of three-dimensional MR-defined neurovascular compression for the pathogenesis of trigeminal neuralgia Harald MasurKarsten PapkeKnut Vollbrecht Original Communication Pages: 93 - 98
Myotonic dystrophy: Correlation of clinical symptoms with the size of the CTG trinucleotide repeat Andrea JaspertRaimund FahsoldDetlef Claus Original Communication Pages: 99 - 104
Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction Yee-Wen ChiaClare J. FowlerMichael Swash Original Communication Pages: 105 - 108
Scalp potentials recorded over the sensorimotor region following magnetic stimulation over the cerebellum in man: Considerations about the activated structures and their potential diagnostic use B. -U. MeyerS. Röricht Letters to the Editors Pages: 109 - 112
Preclinical stages in subjects at risk for neurological disorders: Can PET FDG tell us more? Nina P. AzariPietro Pietrini Letter to the Editors Pages: 112 - 114
Isolated idiopathic adult-onset foot dystonia and treatment with botulinum toxin J. DuarteF. A. FrenchL. E. Clavería Letter to the Editors Pages: 114 - 115